Vinay Chandrakant Suhanda
About Vinay Chandrakant Suhanda
Data last updated:
Vinay Chandrakant Suhanda has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Infevcrex Industries Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Infevcrex Industries Private Limited at ₹9.1 Lakh (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Infevcrex Industries Private Limited U74999GJ2019PTC107012 | Director | 11 Mar 2019 | 2019 | ₹9.1 Lakh (FY 2021) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vinay Chandrakant Suhanda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vinay Chandrakant Suhanda
Vinay Chandrakant Suhanda has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Infevcrex Industries Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Infevcrex Industries Private Limited at ₹9.1 Lakh (FY 2021).
Vinay Chandrakant Suhanda is associated with 1 company as Director, including Infevcrex Industries Private Limited (₹9.1 Lakh).
Vinay Chandrakant Suhanda has expertise in General Business.
Vinay Chandrakant Suhanda has 7 years in corporate governance.
By reported revenue, the largest current company of Vinay Chandrakant Suhanda is Infevcrex Industries Private Limited, with revenue of ₹9.1 Lakh (FY 2021).
Vinay Chandrakant Suhanda currently holds positions at 1 company: Infevcrex Industries Private Limited (₹9.1 Lakh).